European Archives - Page 25 of 1164 - European Medical Journal

Resistance Persists Years After Azithromycin Mass Drug Administration

Azithromycin mass drug administration may promote durable and transmissible resistance, including in populations not directly exposed.

Mindful Parenting Improves Outcomes in Children With Asthma and ADHD

A structured parenting programme based on acceptance and commitment therapy has shown clinical benefits in managing asthma and ADHD symptoms in children.

Age and Sex Differences in Carotid Plaque Progression Revealed by MRI

Subclinical carotid plaques with calcification are more prone to develop dangerous haemorrhages, especially in older men.

Elderly Face More Complications in Rectal Cancer Surgery

Research shows patients over 70 experience more complications and a higher death rate following rectal cancer surgery compared to younger patients.

Diabetes and Hypertension Could Double Mortality Risk

Dual burden of diabetes and hypertension more than doubles cardiovascular death risk, especially in women, study finds.

EMJ Oncology 13 [Supplement 3] 2025

Overcoming Resistance: How Targeted Approaches Are Changing Management of Advanced EGFR-Mutant Lung Cancer and Pavingthe Way for Precision…

How Targeted Approaches Are Transforming Management of Advanced EGFR-Mutant Lung Cancer

Overcoming Resistance: How Targeted Approaches Are Changing Management of Advanced EGFR-Mutant Lung Cancer and Pavingthe Way for Precision…

Hyperinsulinaemia Linked to Abnormal Uterine Bleeding in Reproductive-Aged Women

Women with high insulin levels may be more likely to experience abnormal uterine bleeding, according to a new study exploring metabolic contributions to gynecologic symptoms.

Efruxifermin Improves Fibrosis in Long-Term MASH Study

In this double-blind, placebo-controlled trial, 181 participants were randomised to receive weekly injections of either 28 mg or 50 mg of efruxifermin or a placebo.

Midlife Health Conditions Linked to Increased Cancer Risk

A new study of nearly 129,000 adults has revealed that common midlife comorbidities, such as respiratory and cardiovascular conditions, are associated with an increased risk of cancer and cancer-related death.